Evidence map›Paper›PMID 24866468›Full record

ArticlePloS one2014

Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Andrew F Auld, Kunomboa A Ekra, Ray W Shiraishi, Moise Z Tuho, Joseph S Kouakou, Fayama Mohamed, Virginie Ettiègne-Traoré, Jennifer Sabatier, Joseph Essombo, Georgette Adjorlolo-Johnson and 2 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrew F AuldDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kunomboa A EkraDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Abidjan, Côte d'Ivoire.
Ray W ShiraishiDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Moise Z TuhoNational Program for Medical Care of Persons Living with HIV/AIDS, Ministry of Health, Abidjan, Côte d'Ivoire.
Joseph S KouakouElizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
Fayama MohamedElizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire; Department of Economy and Finance, Directorate General of Budget and Finance, Abidjan, Côte d'Ivoire.
Virginie Ettiègne-TraoréNational Program for Medical Care of Persons Living with HIV/AIDS, Ministry of Health, Abidjan, Côte d'Ivoire.
Jennifer SabatierDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Joseph EssomboElizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
Georgette Adjorlolo-JohnsonElizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America.
Richard MarlinkElizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America.
Tedd V EllerbrockDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Funding

PEPFAR
6 · The paper itself

Abstract

backgroundIn Côte d'Ivoire during 2004-2007, numbers of ART enrollees increased from <5,000 to 36,943. Trends in nationally representative ART program outcomes have not yet been reported. METHODOLOGY/PRINCIPAL

findingsWe conducted a retrospective chart review to assess trends in patient characteristics and attrition [death or loss to follow-up (LTFU)] over time, among a nationally representative sample of 3,682 adults (≥15 years) initiating ART during 2004-2007 at 34 health facilities. Among ART enrollees during 2004-2007, median age was 36, the proportion female was 67%, the proportion HIV-2-infected or dually HIV-1&2 reactive was 5%, and median baseline CD4+ T-cell (CD4) count was 135 cells/µL. Comparing cohorts initiating ART in 2004 with cohorts initiating ART in 2007, median baseline weight declined from 55 kg to 52 kg (p = 0.008) and the proportion weighing <45 kg increased from 17% to 22% (p = 0.014). During 2004-2007, pharmacy-based estimates of the percentage of new ART enrollees ≥95% adherent to ART declined from 74% to 60% (p = 0.026), and twelve-month retention declined from 86% to 69%, due to increases in 12-month mortality from 2%-4% and LTFU from 12%-28%. In univariate analysis, year of ART initiation was associated with increasing rates of both LTFU and mortality. Controlling for baseline CD4, weight, adherence, and other risk factors, year of ART initiation was still strongly associated with LTFU but not mortality. In multivariate analysis, weight <45 kg and adherence <95% remained strong predictors of LTFU and mortality.

conclusionsDuring 2004-2007, increasing prevalence among ART enrollees of measured mortality risk factors, including weight <45 kg and ART adherence <95%, might explain increases in mortality over time. However, the association between later calendar year and increasing LTFU is not explained by risk factors evaluated in this analysis. Undocumented transfers, political instability, and patient dissatisfaction with crowded facilities might explain increasing LTFU.

Indexed as

HIV-1HIV-2AdultAnti-HIV AgentsFemaleFollow-Up StudiesHIV InfectionsHumansMaleMortalityProgram EvaluationRetrospective StudiesRisk FactorsSurvival RateTreatment OutcomeAnti-HIV Agents

Identifiers

PMID24866468
PMCPMC4035349

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.